APA-viite

Cuncannon, M., Wong, M., Jayamanne, D., Guo, L., Cove, N., Wheeler, H., & Back, M. (2019). Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma. BMC Cancer.

Chicago-tyylinen lähdeviittaus

Cuncannon, Moire, Matthew Wong, Dasantha Jayamanne, Linxin Guo, Nicola Cove, Helen Wheeler, ja Michael Back. "Role of Delayed Salvage Bevacizumab At Symptomatic Progression of Chemorefractory Glioblastoma." BMC Cancer 2019.

MLA-viite

Cuncannon, Moire, et al. "Role of Delayed Salvage Bevacizumab At Symptomatic Progression of Chemorefractory Glioblastoma." BMC Cancer 2019.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.